London-based health technology platform reports 100,000 mobile downloads in two months and expands multilingual lab analysis to 75+ languages
— Kantesti (kantesti.net), an AI-powered blood test interpretation platform for individuals and healthcare providers, has surpassed 2 million users across 127 countries. The platform applies a proprietary neural network to laboratory data, generating plain-language explanations of blood test results across more than 15,000 biomarkers in 75+ languages. Kantesti is operated by Kantesti Ltd (UK Companies House No. 17090423), headquartered in London.
Key Figures
2 million+ registered users across 127 countries as of March 2026
100,000+ Google Play downloads within the first two months of the mobile app launch (November 2025)
15,000+ supported biomarkers across standard and specialized laboratory panels
75+ languages available for report generation, including underserved language markets
Technology partnerships: Microsoft for Startups (Founders Hub), NVIDIA Inception Program, Google Cloud
Platform methodology and clinical validation details are published at kantesti.net/medical-validation.
How Kantesti Interprets Blood Test Results
Laboratory reports typically contain dozens of biomarkers, reference ranges, and clinical indicators. Interpreting this data without specialist training is difficult. As more individuals receive lab results through digital health portals and direct-to-consumer testing services, the need for structured interpretation tools has grown.
Kantesti’s neural network analyzes common laboratory panels—complete blood counts, metabolic panels, lipid profiles, liver and kidney function markers, thyroid panels, and vitamin assays—and generates plain-language summaries. Each report includes parameter-level explanations, reference range context, and areas that may warrant discussion with a healthcare provider.
The platform also provides a blood test comparison tool for tracking changes across multiple reports, trend analysis for monitoring specific parameters over time, a nutrition module that generates meal plans informed by lab results, and a family health feature for identifying hereditary risk patterns. These tools are designed to support personal health understanding—not to replace clinical evaluation or medical advice.
Founder Statement
“Most people receive their lab results as a list of numbers with little context,” said Julian Emirhan Bulut, CEO and Founder of Kantesti. “We built this platform to help users understand what those numbers mean in plain language. The goal has always been to support health literacy and better-informed conversations with doctors—not to substitute for professional medical judgment. Reaching 2 million users tells us the demand for this kind of tool is real and growing.”
Background on the founding team and platform history is available at kantesti.net/about-us.
Use Cases for Clinics and Laboratories
In addition to individual users, Kantesti serves healthcare professionals through a dedicated clinic dashboard. Clinics and diagnostic laboratories can use the platform to streamline patient communication around lab results, support batch report processing, and access customizable supplement recommendation libraries. The platform is designed to reduce time spent on routine result explanations without adding operational complexity.
Kantesti complies with GDPR and HIPAA data protection standards and holds CE marking for the European market. Technical documentation and API details for healthcare integration are available on the platform’s website.
AI Lab Test Analysis in Context
AI-powered health diagnostics tools are increasingly used to provide structured context for laboratory data. These tools do not diagnose conditions or prescribe treatments. They organize and explain raw lab values so that users can approach healthcare providers with a better baseline understanding of their results.
Kantesti operates in this space alongside other AI lab test analysis platforms, with a focus on multilingual accessibility, breadth of biomarker coverage, and structured output that distinguishes between normal findings and areas that may warrant clinical follow-up. The platform is available via web, iOS, and Android.
About Kantesti
Kantesti is an AI-powered health technology platform specializing in blood test interpretation. Founded in 2019 and headquartered in London, United Kingdom (Kantesti Ltd, UK Companies House No. 17090423), the platform serves over 2 million users across 127 countries. Kantesti’s proprietary neural network interprets more than 15,000 biomarkers and generates structured health reports in 75+ languages via web and mobile applications. The platform holds partnerships with Microsoft for Startups, NVIDIA Inception, and Google Cloud, and maintains CE marking, HIPAA, and GDPR compliance.
Website: www.kantesti.net
Medical Validation: kantesti.net/medical-validation
About the Team: kantesti.net/about-us
Contact Info:
Name: Julian Emirhan Bulut, CEO & Founder
Email: Send Email
Organization: Kantesti Ltd
Website: https://www.kantesti.net/
Release ID: 89187862
If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.